Puricore Share Discussion Threads

[cerrito] 16/11/2016 17:55

I took today’s RNS as saying that there has been a delay on PR013 following the IND meeting with the FDA.
In the October 10 RNS they referred to quote We have already made good progress this year with two INDs on track for submission in Q1 2017 unquote and now they are saying that PR013 has moved back to Q3 after the IND meeting. This repeated what they said in their September Interims announcement
Quote We are on track to submit two INDs in Q1 2017. unquote
Is that how everyone else reads this?

[hatey] 20/9/2016 08:43

13 mil now so 50% rise needed to get to cash level or around 38-40p

Not that it will, it should but when does it guarantee that happens.

But it certainly should be over 30p

[wigwammer] 20/9/2016 07:46

Looks like good news.Will leave them with circa £20m cash and a very interesting drug platform.Current market cap £11m.

[love it] 29/3/2016 16:08

mm's must be delaying the trade.

29 March 2016

PuriCore plc

("PuriCore" or the "Company")

Director Dealing

29 March 2016 - PuriCore plc (AIM: PURI), announces that, Alex Martin, Chief Executive Officer and Executive Director of the Company, today purchased ordinary shares of 10p each in the share capital of the Company ("Shares").


% of
Number Purchase Shareholding issued
of Shares price following share
Name Date purchased purchased of Shares the purchase capital
29 March
Alex Martin 2016 100,000 28p 100,000 0.20%

[love it] 15/3/2016 15:54

" The Company expects to report full year results by the end of March 2016"

Might also be a sale of business to report with those results leaving the company
with way more cash than market cap. Does look very promising.

[love it] 14/3/2016 09:09

dream chart

[love it] 09/3/2016 12:00

Lovely chart

[love it] 16/2/2016 10:07

Moving again. Informed possible overhang has been cleared.

[love it] 13/2/2016 14:55

100k buy yesterday £23.4k not smallfry

[love it] 11/2/2016 10:42

Nice post Premier1

Company results end of March. Can see Directors buying more if price stays this low.

[love it] 09/2/2016 13:30

Had another 10k at 23.9p not sure I would called it a distressed seller but it looks
suspicious that it's just one person dropping blocks around 25k today. Guess when they are finished the price will rise again.

[danwaits] 08/2/2016 13:58

Riddle, before bigging up any outfit, I think that it's always best to take a peek at past and current performance, especially as early investors in this POS are down almost 95% on their original investments.

Two years ago, Puri had two revenue generating divisions; the loss making supermarket business and the endoscopy business which was generating $2m PBT.

So, guess which one did they sold?

Now they claim growing revenues in the remaining retail side (due mainly to one-off sales of dosing units), but most likely the business remains unprofitable.

Solution - "Let's abandon all existing revenue streams and get into the prescription drugs business, which we know absolutely FA about, apart from what some consultant chappies have told us. And let's also recruit some suitable souls to help us spend the last of our share-holders funds as we chase some blue-sky dreams. Gosh, we're brilliant altogether, what spiffingly wonderful money managers we are"

[riddlerone] 08/2/2016 09:18

So market cap roughly the same as cash balance,possible sale of $20m plus turnover business and a year away from two IND applications with the FDA (Q1 2017)!!!

[riddlerone] 04/1/2016 11:44

Lots of cash here that was decided by the board to not return to shareholders.Mr Newton is no fool and by building a large shareholding could begin to influence the direction of their decisions.

[love it] 14/10/2015 17:27

This just might get a bit more interesting.

14 October 2015

PuriCore plc

("PuriCore" or the "Company")

Director Dealing

14 October 2015 - PuriCore plc (AIM: PURI), an international company focused on applying its proprietary hypochlorous acid platform technology to unmet needs in human health, announces that, on 14 October 2015, the Director named below notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares").

% of
Number Purchase Shareholding issued
of Shares price following the share
Name Date purchased purchased of Shares purchase capital
Daniel Hegglin
Non-Executive
Director 13 October 2015 500,000 18p 5,909,091 11.79%

[love it] 14/10/2015 16:08

Looks ripe for a bounce so bought in today.

[gfrae] 23/9/2015 13:47

Now we all know. Apparently the second half is expcted to be much better.

[gfrae] 20/8/2015 15:34

Does anyone know why the shares are weak now - is it just "the market" or something specific ?

[meijiman] 19/3/2015 12:58

Maybe that his hit the nail on the head. Must be some reason for the lowly rating..